340 related articles for article (PubMed ID: 19865100)
1. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P
J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100
[TBL] [Abstract][Full Text] [Related]
2. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
Yanagihori H; Oyama N; Nakamura K; Kaneko F
J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
[TBL] [Abstract][Full Text] [Related]
3. KIT masters mast cells in kids, too.
Kambe N; Longley BJ; Miyachi Y; Kabashima K
J Invest Dermatol; 2010 Mar; 130(3):648-50. PubMed ID: 20145643
[TBL] [Abstract][Full Text] [Related]
4. Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.
Arase N; Wataya-Kaneda M; Murota H; Nakagawa Y; Yamaoka T; Itoi-Ochi S; Hirayasu K; Arase H; Fujimoto M; Katayama I
J Dermatol; 2020 Apr; 47(4):426-429. PubMed ID: 32077120
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
6. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
7. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
9. Kit Mutations: New Insights and Diagnostic Value.
Falchi L; Verstovsek S
Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
[TBL] [Abstract][Full Text] [Related]
10. Identification of KIT activating mutations in paediatric solitary mastocytoma.
Ma D; Stence AA; Bossler AB; Hackman JR; Bellizzi AM
Histopathology; 2014 Jan; 64(2):218-25. PubMed ID: 24128084
[TBL] [Abstract][Full Text] [Related]
11. The genetic basis of mast cell activation disease - looking through a glass darkly.
Molderings GJ
Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
[TBL] [Abstract][Full Text] [Related]
12. Paediatric mastocytosis: a systematic review of 1747 cases.
Méni C; Bruneau J; Georgin-Lavialle S; Le Saché de Peufeilhoux L; Damaj G; Hadj-Rabia S; Fraitag S; Dubreuil P; Hermine O; Bodemer C
Br J Dermatol; 2015 Mar; 172(3):642-51. PubMed ID: 25662299
[TBL] [Abstract][Full Text] [Related]
13. A c-kit mutation in exon 18 in familial mastocytosis.
Wöhrl S; Moritz KB; Bracher A; Fischer G; Stingl G; Loewe R
J Invest Dermatol; 2013 Mar; 133(3):839-841. PubMed ID: 23190889
[No Abstract] [Full Text] [Related]
14. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
Verzijl A; Heide R; Oranje AP; van Schaik RH
Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
[TBL] [Abstract][Full Text] [Related]
15. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
Chan IJ; Tharp MD
Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
[TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
Li Y; Li X; Liu X; Kang L; Liu X
J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
[TBL] [Abstract][Full Text] [Related]
18. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.
Longley BJ; Metcalfe DD; Tharp M; Wang X; Tyrrell L; Lu SZ; Heitjan D; Ma Y
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1609-14. PubMed ID: 9990072
[TBL] [Abstract][Full Text] [Related]
19. Novel R634W c-kit mutation identified in familial mastocytosis.
Pollard WL; Beachkofsky TM; Kobayashi TT
Pediatr Dermatol; 2015; 32(2):267-70. PubMed ID: 25243845
[TBL] [Abstract][Full Text] [Related]
20. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
